Why this guide exists
Thousands of UK searches every month ask how much bacteriostatic water to mix with a peptide vial, how to calculate doses in "units", and how to dilute compounds like retatrutide. Behind each search is usually a person with an unlabelled vial from an online seller, a insulin syringe, and a forum thread for instructions. This guide explains — without judgement — why that process is far riskier than the forums suggest, and what the regulated alternative looks like.
What reconstitution actually involves
Peptides degrade in solution, so grey-market products ship as freeze-dried powder that must be dissolved ("reconstituted") before injection. In a pharmaceutical setting this is done by trained staff, with sterile diluents, laminar-flow hoods, validated concentrations and labelled stability windows. At a kitchen table it is done with a vial of uncertain contents, a syringe of bacteriostatic water from the same unregulated market, and arithmetic copied from strangers.
Every step carries a failure mode. Non-sterile technique introduces bacteria into a product that will be injected under the skin. Mis-measured diluent changes the concentration, so even a "correct" syringe volume delivers the wrong dose. Warm storage, shaking or repeated punctures degrade the peptide unpredictably. And because the starting powder is unverified, the calculation can be perfect and the dose still wrong.
The dosing trap: units, milligrams and guesswork
Insulin syringes measure "units" of volume, but a unit of volume only maps to a dose if the concentration is known and correct. Grey-market instructions juggle milligrams of powder, millilitres of water and units on a syringe — three conversions, each depending on an unverified label. Dosing errors of several-fold are easy, and with hormonally active compounds a several-fold overdose is not a rounding error: it is vomiting, dehydration, hypoglycaemia or worse, at home, with no one monitoring.
There is no "safe protocol" to find
The search that leads people here — the right ratio, the proper calculator — assumes a validated answer exists. It does not. For unlicensed compounds like retatrutide there is no approved preparation protocol outside clinical trials, because the products themselves are outside the system that creates such protocols. Any confident instructions you find are anecdote wearing a lab coat. The legal position is covered in our guides to peptide legality in the UK and retatrutide specifically.
"Research use only" does not protect you
Grey-market peptide sellers lean on a legal fig leaf: the label says the product is for laboratory research, not human use. The label does not change what the product is — an unverified injectable — and it does not transfer risk away from the person injecting it. What it mainly does is signal that no one in the supply chain accepts responsibility for what happens next: no batch testing you can audit, no pharmacovigilance, no recall mechanism, no liability. In a regulated supply chain, every one of those exists and is enforceable.
The same applies to the accessories. Bacteriostatic water, syringes and alcohol swabs from the same marketplaces carry the same verification gap, and sterile technique is a chain that fails at its weakest link. People who would never take an unlabelled tablet from a stranger routinely inject the liquid equivalent because the vial looks clinical. Appearance is the cheapest thing to fake.
What the regulated route gives you instead
Licensed injectable weight-loss treatments — Wegovy and Mounjaro — arrive as pre-filled pens: pharmaceutical-grade compound, exact dose, sterile device, no mixing, no maths. Prescribing comes with dose-escalation schedules, side-effect support and a clinician who knows your history. And if injections themselves are the barrier, a licensed once-daily tablet now exists — see our guide to Foundayo (orforglipron).
If you are researching reconstitution because you want effective weight-loss treatment, the honest advice is that the regulated route is safer on every axis that matters — start with a consultation with a UK-registered clinician.
None of this is theoretical. UK clinicians have described treating infections, dosing emergencies and severe dehydration in people who prepared grey-market peptides at home, and poison-information services field calls about exactly the miscalculations this guide describes. The pattern is consistent: the injection was easy; it was everything around the injection that failed.
It is no accident that licensed injectables in this field ship as fixed-dose pens rather than vials and syringes. Regulators require dosing systems that ordinary patients can use accurately at home, and manufacturers spend years engineering out exactly the failure modes this guide describes — concentration errors, contamination, degradation, misread syringes. The pen is the answer to a safety problem the grey market re-creates and hands back to you.
The parts nobody mentions: sharps, storage and disposal
Injecting at home creates obligations the forums skip. Used needles are clinical waste — UK households are expected to use a proper sharps bin and a council or pharmacy disposal route, not a drinks bottle in the kitchen bin that endangers waste handlers. Reconstituted peptides are also perishable: they need refrigeration, have short and uncertain use-by windows (uncertain because nothing about the product is validated), and degrade invisibly. A vial that looks fine can be a vial of inactive fragments — or of something growing.
Storage and stability myths
Grey-market lore holds that bacteriostatic water makes a vial safe for weeks, that refrigeration guarantees potency, and that a peptide either "works or it doesn't". None of this is reliable. Bacteriostatic water inhibits some bacterial growth; it does not sterilise a contaminated product or stop chemical degradation. Refrigeration slows decay without defining it — validated stability windows come from testing that unlicensed products never receive. And degraded peptides are not simply weaker: breakdown products have their own, unstudied effects. Licensed pens make all of this someone else's professionally regulated problem.
The questions worth asking before injecting anything
Whatever you decide, ask these questions honestly: Do I actually know what is in this vial, and who verified it? What dose am I really drawing up, and what is that certainty based on? Who will notice if something goes wrong tonight? What is my plan for persistent vomiting, an infected injection site, or symptoms I cannot explain? For licensed treatment, every one of those questions has an institutional answer — a verified product, a printed dose, a prescriber, a pharmacist, and NHS 111. For a kitchen-table vial, every answer is "me, hopefully". That gap is the real risk assessment.